Launch: Testosterone substitute therapy (TRT) for man hypogonadism is certainly quickly gathering popularity and approval. and 14% reported dis-satisfaction. Fulfillment rates were equivalent between gels (68%) shots (73%) and implantable pellets (70%). Doctor suggestion was the only real significant cause forpatients preferring gel-based TRT (66% vs. 37% shot users vs. 31% pellet users). Injectable TRT… Continue reading Launch: Testosterone substitute therapy (TRT) for man hypogonadism is certainly quickly